{
  "abstract": "Over the past two decades, attention-deficit/hyperactivity disorder (ADHD) has morphed from an obscure clinical label into one of the most common — and lucrative — childhood diagnoses on the planet. What began as a narrow and specific condition is now a sprawling, culturally normalized label applied to millions of school-aged children, often with little resistance and with life-altering consequences.This presentation draws on both personal and professional experience. One of us exposed the world’s highest ADHD drug prescribing rates in Eastern Virginia more than 30 years ago, and paid a heavy price for her whistleblowing, while the other co-authored Selling Sickness, a book that 20 years ago documented how industries expand disease definitions to serve commercial interests. It addresses how we might begin to reverse the ever-rising reliance on psychiatric labels and drugs to respond to troubled and troubling children.The ADHD story is not just about a pharmaceutical industry cashing in on childhood behavior. It’s about a system-wide shift in how our society defines normality. Classrooms under pressure, school psychologists eager to ‘help,’ parents desperate for solutions, and physicians trained to prescribe rather than question — all play starring roles in the medicalization of healthy children. Together, this web of influence has normalized the idea that youthful energy, defiance, and restlessness represent a medical defect in need of pharmacological ‘correction.’ADHD became a global market not through deception in isolation, but through cultural complicity – through an ‘overstory’ that has unconsciously shaped our thinking and behavior. Radical transparency about the magnitude of unnecessary psychiatric labelling and prescribing could shift the prevailing narrative and begin to ‘unsell’ ADHD. Electronic health record data could readily be de-identified and aggregated at the community or school zone level to allow citizens to grasp the enormity of the problem and to demand changes to move toward a future where childhood isn’t pathologized for profit.Objectives This presentation explores how Attention-Deficit/Hyperactivity Disorder (ADHD) has been transformed from a rare clinical diagnosis into a mass-market identity that now entraps millions of children, particularly in the United States. Our aim is to expose the mechanisms — both commercial and cultural — that drive this trend, highlighting the intersection of pharmaceutical marketing, school systems, and parental expectations. We challenge the view that ADHD is simply a medical issue, arguing instead that it is a constructed problem, born of profit motives, classroom management pressures, and a deep societal discomfort with behavioural non-conformity. By revisiting both the data and the social forces that led to this explosion of childhood psychiatric drug use, we propose ways to reverse the medicalization of childhood. Our objective is not only to diagnose the problem, but to offer pathways toward a more humane, evidence-based response to children’s struggles that does not lead to automatic prescriptions.Method Our approach blends personal, historical, and epidemiological perspectives. Drawing on more than 30 years of fieldwork, publications, and whistleblower experiences, we dissect how ADHD’s diagnostic boundaries have been expanded and normalized through a carefully orchestrated interplay of pharmaceutical promotion, professional advocacy, and cultural acceptance. Using the Eastern Virginia case — where ADHD drug prescribing once reached world-record levels — we illustrate how local patterns reveal global problems. This is paired with a critical review of how ‘disease awareness’ campaigns and professional guidelines act as disguised marketing, erasing the boundary between education and promotion. We also explore how parents, teachers, school counselors, and clinicians — often unintentionally — become co-opted into perpetuating this cycle. Finally, we propose a public health solution rooted in transparency: leveraging anonymized electronic health data to empower communities to detect, discuss, and ultimately push back against the overdiagnosis and overtreatment of childhood behavior.Results Our review of historical prescribing trends and field experience demonstrates that ADHD’s rise is not solely a medical success story but rather a testament to the success of ‘disease mongering.’ Expanding diagnostic definitions, reshaping public narratives, and aligning professional guidelines with commercial interests helped normalize the pathologizing of normal childhood behaviors. In Eastern Virginia, once the world’s prescribing epicenter, rates soared as clinicians, schools, and families converged around medicating non-conforming children rather than addressing environmental or social contributors to their struggles. Nationally, this same script has played out with remarkable consistency. The result is a generation of children, particularly boys, funneled toward stimulant use on the basis of behavioral differences rather than genuine disease. Our findings underscore the urgent need for community-level surveillance of psychiatric drug prescribing, and for public health frameworks that favor resilience-building over medicalization.Conclusions The ADHD epidemic is less about the discovery of a disease and more about the construction of one. Over the past two decades, we have witnessed the normalization of drugging children into classroom compliance — an act made possible only through the coordinated actions of pharmaceutical companies, medical professionals, school systems, and parents, all embedded in a culture that equates emotional and behavioral difficulty with biomedical defect. To prevent overdiagnosis in the future, it is critical to resist narratives that frame youthful non-conformity as pathology, and to promote societal responses that recognize the role of family, schooling, and environment. Transparency in prescribing patterns and honest conversations about the long-term risks of stimulant use are essential first steps toward ‘unselling’ ADHD and de-medicalizing childhood itself.",
  "authors": [
    {
      "affiliations": [
        "Self-employed, Vicdtoria, Canada"
      ],
      "name": "Alan Cassels"
    },
    {
      "affiliations": [
        "University of South Carolina, SLS, Clinical Psychologist, Virginia Beach, USA"
      ],
      "name": "Gretchen Lefever Watson"
    }
  ],
  "title": "104 ‘Selling ADHD: how the pharmaceutical industry, schools, and parents helped medicalize childhood restlessness — and how we can unsell it’",
  "uid": "817748f4-e9f9-5363-98b1-cd264d9adbcb"
}